Igor Fisch, PhD, Chairman of the Board
Igor Fisch is the Chief Executive Officer of Selexis and Chairman of the Board of Directors. He is an accomplished protein chemist and molecular biologist. Igor completed his post-doctoral studies in the laboratory of Prof. Sir Greg Winter at the Medical Research Council in Cambridge, UK. He joined the Center for Biotechnology UNIL-EPFL in Lausanne Switzerland as a group leader, working in the field of molecular evolution and peptide discovery. In parallel to his research and teaching activities, he received the De Vigier Prize and the NETS Best Prize with training in entrepreneurship both at the EPFL in Lausanne and at the Babson College in Boston, USA.
Nicolas Mermod, Prof., director
Nicolas Mermod is Professor of Biotechnology at Faculty of Biology and Medicine of the University of Lausanne. After completing his post-doctoral studies at the University of California, Berkley, USA, he joined the University of Lausanne as an assistant Professor of the Swiss National Science Foundation to become a full professor in the Department of Biology. Nicolas Mermod exerts teaching and research activities, heading a laboratory of over 20 scientists at the Center for Biotechnology UNIL-EPFL. He has gained a reputation in the field of molecular biology and the control of gene expression and he has authored a number of scientific publications and patents.
Peter Pfister, PhD, director
After completing his PhD in economics at the University of Basel in Switzerland, he held several positions in General management and finance in Switzerland, France and in the USA. Peter Pfister is a former CFO of Adecco SA, a publicly traded company with sales of CHF 25 billion. He also served as President of Adecco North America and President of Adecco’s Professional Staffing and Services Division. Peter Pfister is now a consultant and a private investor.
Gian-Luigi Berini, director & entrepreneur
Gian-Luigi became a board member in April 2005 . He is managing a technology based start-up company, active in the Life Science Industry. In addition, Gian-Luigi is the Director of FONGIT, Geneva’s hi-tech business incubator. In this capacity, he represents the CTN, Fongit’s Seed-Money Fund, and the Fongit on the board of directors of Selexis. Gian-Luigi spent more than 10 years as line- and general manager in multinational companies such as Alusuisse. Gian-Luigi studied economy at the University of Zurich, his expertise is in the field of Sales & Marketing, Organization and General Management.